UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.431-439

2018

Volltextzugriff (PDF)

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin

Alimentary pharmacology & therapeutics, 2012-06, Vol.35 (12), p.1434-1442

2012

Volltextzugriff (PDF)

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

Gut, 2010-05, Vol.59 (5), p.638-644

2010

Volltextzugriff (PDF)

Editorial: real‐life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease

Alimentary pharmacology & therapeutics, 2018-07, Vol.48 (2), p.226-227

2018

Volltextzugriff (PDF)

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”

Journal of hepatology, 2020-12, Vol.73 (6), p.1570-1571

2020

Volltextzugriff (PDF)

Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients

Gut, 2005-03, Vol.54 (3), p.402-406

2005

Volltextzugriff (PDF)

A randomized, controlled trial of a 24‐month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

Hepatology (Baltimore, Md.), 1997-12, Vol.26 (6), p.1621-1625

1997

Volltextzugriff (PDF)

Performance of the COBAS AMPLICOR HCV MONITOR Test, Version 2.0, an Automated Reverse Transcription-PCR Quantitative System for Hepatitis C Virus Load Determination

Journal of Clinical Microbiology, 2000-06, Vol.38 (6), p.2210-2214

2000

Volltextzugriff (PDF)

Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy

Journal of viral hepatitis, 2013-12, Vol.20 (12), p.858-866

2013

Volltextzugriff (PDF)

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data

Gut, 2002-12, Vol.51 (6), p.864-869

2002

Volltextzugriff (PDF)

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial

Journal of viral hepatitis, 2014-07, Vol.21 (7), p.458-465

2014

Volltextzugriff (PDF)

Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients

Transfusion (Philadelphia, Pa.), 2004-05, Vol.44 (5), p.790-794

2004

Volltextzugriff (PDF)

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFN alpha 2a and Ribavirin: a randomized controlled trial

Journal of viral hepatitis, 2014-07, Vol.21 (7), p.458-465

2014

Volltextzugriff (PDF)

The natural history of asymptomatic hepatitis B surface antigen carriers

Annals of internal medicine, 1993-02, Vol.118 (3), p.191

1993

Volltextzugriff (PDF)

Hepatitis C virus RNA profiles in chronically infected individuals: Do they relate to disease activity?

Hepatology (Baltimore, Md.), 1999-02, Vol.29 (2), p.585-589

1999

Volltextzugriff (PDF)

The Low Risk of Hepatitis C Virus Transmission Among Sexual Partners of Hepatitis C-Infected Hemophilic Males: An International, Multicenter Study

Blood, 1992-07, Vol.80 (2), p.540-543

1992

Volltextzugriff (PDF)

Hepatitis C in haemophilia: lights and shadows

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-10, Vol.10 (s4), p.211-215

2004

Volltextzugriff (PDF)

Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients

Journal of viral hepatitis, 2014-06, Vol.21 (6), p.416-423

2014

Volltextzugriff (PDF)

Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough

Journal of viral hepatitis, 2002-01, Vol.9 (1), p.71-74

2002

Volltextzugriff (PDF)

Long-term response to interferon alpha is unrelated to“interferon sensitivity determining region” variability in patients with chronic hepatitis C virus-1b infection

Journal of hepatology, 1999-06, Vol.30 (6), p.1023-1027

1999

Volltextzugriff (PDF)

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

The Journal of clinical investigation, 1996-08, Vol.98 (3), p.706-714

1996

Volltextzugriff (PDF)

Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy

Journal of thrombosis and haemostasis, 2009-12, Vol.7 (12), p.1997-2005

2009

Volltextzugriff (PDF)

Primary prophylaxis of variceal bleeding in cirrhotic patients: A cohort study

Digestive and liver disease, 2008-12, Vol.40 (12), p.936-943

2008

Volltextzugriff (PDF)

Recovery after l -DOPA treatment in peginterferon and ribavirin induced parkinsonism

European journal of internal medicine, 2008-07, Vol.19 (5), p.370-371

2008

Volltextzugriff (PDF)

Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate

Transfusion (Philadelphia, Pa.), 1995-03, Vol.35 (3), p.209-212

1995

Volltextzugriff (PDF)

1 – 25 von 530

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(482)
Mit Volltextzugriff
(438)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin

The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

Editorial: real‐life data confirm efficacy of elbasvir/grazoprevir in HCV patients with severe kidney disease

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”

Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients

A randomized, controlled trial of a 24‐month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

Performance of the COBAS AMPLICOR HCV MONITOR Test, Version 2.0, an Automated Reverse Transcription-PCR Quantitative System for Hepatitis C Virus Load Determination

Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial

Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFN alpha 2a and Ribavirin: a randomized controlled trial

The natural history of asymptomatic hepatitis B surface antigen carriers

Hepatitis C virus RNA profiles in chronically infected individuals: Do they relate to disease activity?

The Low Risk of Hepatitis C Virus Transmission Among Sexual Partners of Hepatitis C-Infected Hemophilic Males: An International, Multicenter Study

Hepatitis C in haemophilia: lights and shadows

Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients

Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough

Long-term response to interferon alpha is unrelated to“interferon sensitivity determining region” variability in patients with chronic hepatitis C virus-1b infection

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy

Primary prophylaxis of variceal bleeding in cirrhotic patients: A cohort study

Recovery after l -DOPA treatment in peginterferon and ribavirin induced parkinsonism

Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate

Aktive Filter

Suchergebnisse filtern